Institute hosts inaugural VCU 3D Summit
The first VCU 3D Summit, a day of discovering drug discovery and development at the university, takes place Feb. 4 in Rooms A and B of Biotech One, 800 E. Leigh St. The summit, arranged by the Institute for Structural Biology and Drug Discovery, will feature short talks on current drug topics by faculty from VCU, Tulane University, University of Richmond and Vanderbilt University, as well as industry consultants.
VCU School of Pharmacy professor Umesh Desai is director of the institute. The event is free of charge, but registration is requested by contacting Michelle Wise at mcwise@vcu.edu or (804) 828-3899.
The program is as follows. Each talk will end with a 10-minute question-and-answer session. Speakers are with VCU unless otherwise indicated:
7:30-8:15 a.m. Coffee and light snacks
8:15-8:30 a.m. Welcome, School of Pharmacy Dean Joseph T. DiPiro
8:30-9 a.m. “Novel Inhibitors of the NLRP3 Inflammasome,” Shijun Zhang and Benjamin Van Tassell, School of Pharmacy; and Antonio Abbate, School of Medicine
9-9:30 a.m. “Sulfated Dehydropolymer of Caffeic Acid for Emphysema,” Masahiro Sakagami, School of Pharmacy, and Norbert Voelkel, School of Medicine
9:30-10 a.m. “Hepadnaviral Core Protein as a Vaccine Carrier Platform,” Darrell Peterson, School of Medicine
10-10:30 a.m. “Non-Saccharide Glycosaminoglycan Mimetics for Selectively Targeting Cancer Stem Cells,” Bhaumik Patel (McGuire VA Hospital and Massey Cancer Center)
10:30-11 a.m. Coffee break
11-11:30 a.m. “Discovery of Novel and Potent Pyrrole-Based Colchicine Site Inhibitors,” Glen Kellogg, School of Pharmacy, and John Gupton, University of Richmond
11:30 a.m.-noon “2-O, 3-O Desulfated Heparin: An Inhaled Anti-Inflammatory Therapy for Cystic Fibrosis,” Judy Voynow, School of Medicine and VCU Health System; Thomas Kennedy, Tulane University; and Peter Byron, School of Pharmacy
Noon-12:30 p.m. “Nevirapine: Increasing the Global Availability of AIDS Drugs,” Frank Gupton, School of Engineering
12:30-1 p.m. “Sulfated Pentagalloylglucopyranose for Thrombosis,” Umesh Desai, School of Pharmacy, and David Gailani, Vanderbilt University
1-2 p.m. Lunch
2-2:40 p.m. “Drug Development Perspective,” Gene Cefali, E.A. Cefali Pharmaceutical Consulting; Tony Coniglio, OPUS Pharma Consulting; and Santosh Vetticaden, Global Drug Development Consulting
2:40-3 p.m. “Preclinical and Clinical Drug Development,” Jürgen Venitz, School of Pharmacy
3-4 p.m. Roundtable discussion: “Institute and Drug Development”
4-4:10 p.m. Conclusion, Umesh Desai, School of Pharmacy
Categories Alumni news, Events, Faculty news, Graduate students, Student news